Vascularization of kidney organoids: different strategies and perspectives
Kidney diseases such as glomerulopathy and nephron dysfunction are estimated to grow to
more than 900M cases by 2030, in 45% of which kidney transplantation will be required …
more than 900M cases by 2030, in 45% of which kidney transplantation will be required …
[HTML][HTML] Generation of chimeric kidneys using progenitor cell replacement: Oshima Award Address 2021
S Yamanaka - Clinical and Experimental Nephrology, 2022 - Springer
It is believed that the development of new renal replacement therapy (RRT) will increase
treatment options for end-stage kidney disease and help reduce the mismatch between …
treatment options for end-stage kidney disease and help reduce the mismatch between …
Replacing renal function using bioengineered tissues
MH Little, TJ Rabelink - Nature Reviews Bioengineering, 2023 - nature.com
Kidney transplantation is at present the only definitive treatment for patients with end-stage
kidney disease that can improve the quality of life compared with dialysis. However, donor …
kidney disease that can improve the quality of life compared with dialysis. However, donor …
[HTML][HTML] Bioengineering platforms for cell therapeutics derived from pluripotent and direct reprogramming
Pluripotent and direct reprogramming technologies hold great potential for tissue repair and
restoration of tissue and organ function. The implementation of induced pluripotent stem …
restoration of tissue and organ function. The implementation of induced pluripotent stem …
Current status and future prospects of decellularized kidney tissue
Y Nishimura - Journal of Artificial Organs, 2023 - Springer
End-stage renal disease (ESRD) is characterized by progressive loss of kidney function,
which can result in damage to various tissues and organs. Dialysis therapy and kidney …
which can result in damage to various tissues and organs. Dialysis therapy and kidney …
[HTML][HTML] Effect of different decellularization protocols on reendothelialization with human cells for a perfused renal bioscaffold of the rat
J Sauter, H Degenhardt, J Tuebel, P Foehr… - BMC …, 2023 - Springer
Background Scaffolds for tissue engineering can be received by whole organ
decellularization while maintaining the site-specific extracellular matrix and the vascular …
decellularization while maintaining the site-specific extracellular matrix and the vascular …
Another piece in the puzzle of kidney fibrosis
Kidney fibrosis is a chronic physiomorphologic transformation of the renal parenchyma.
Despite the known characteristics of the related structural and cellular changes, the …
Despite the known characteristics of the related structural and cellular changes, the …
Preparation and application of acellular scaffold in tissue engineering and regenerative medicine
X Chen, Y Luo, H Bi, K Yang - Chinese Journal of Tissue Engineering …, 2022 - cjter.com
BACKGROUND: Biological scaffolds made from tissue or organ decellularization have been
successfully applied to various tissue engineering and regenerative medicine. OBJECTIVE …
successfully applied to various tissue engineering and regenerative medicine. OBJECTIVE …
Radiopaque thermosensitive Pickering emulsion vascular embolist for permanent arterial embolization
L Li, N Chen, G Cheng, A Liu, L Zhang, J Xing, Y Cao… - 2024 - researchsquare.com
The emergence of liquid embolic agents has advanced the utilization of transcatheter
arterial embolization (TAE). Unlike the conventional solid embolic agent (gelatin …
arterial embolization (TAE). Unlike the conventional solid embolic agent (gelatin …
Patienten mit Analkarzinom und definitiver Radiochemotherapie von 2004-2018 am Klinikum Rechts der Isar: eine retrospektive Analyse
C Sauter - 2022 - mediatum.ub.tum.de
In dieser Arbeit werden die Ergebnisse der primär radiotherapeutischen Behandlung von
Patienten mit einem Analkarzinom von 2004-2018 der Klinik für RadioOnkologie und …
Patienten mit einem Analkarzinom von 2004-2018 der Klinik für RadioOnkologie und …